Mark Trusheim, for NEWDIGS

The FDA Oncology Center of Excellence, in collaboration with the UCSF-Stanford Centers of Excellence in Regulatory Science and Innovation (CERSI) will hold a public workshop to explore clinical trial designs and innovations that will aid in optimizing outcomes in early breast cancer.